Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Phio Pharmaceuticals Corp. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is R. Todd Plott (Form 8-K filed 2026-07-21). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Cvi Investments, Inc. (filed 2026-02-17).
Who is behind it
Phio Pharmaceuticals Corp.: incorporated in Delaware; business address in King Of Prussia, Pennsylvania; industry Pharmaceutical Preparations (Form D, 2026-07-21).
Officers and directors, each with the role and the filing that names them:
- Robert J. Bitterman: Director, Executive Officer (Form D, 2025-11-12)
- Patricia A. Bradford: Director (Form D, 2025-11-12)
- Jonathan Freeman: Director (Form D, 2025-11-12)
- Curtis Lockshin, Ph.D.: Director (Form D, 2025-11-12)
- David H. Deming: Director (Form D, 2025-11-12)
- Lisa Carson: Executive Officer (Form D, 2025-11-12)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-02-17 | Cvi Investments, Inc. | 9.9% |
| Schedule 13G/A, 2026-02-13 | Mitchell P. Kopin | 9.1% |
| Schedule 13G/A, 2025-12-11 | Orca Capital Ag | 4.9% |
| Schedule 13G/A, 2025-11-24 | Orca Capital Ag | 6.5% |
| Schedule 13G/A, 2025-11-12 | Orca Capital Ag | 4.9% |
| Schedule 13G, 2025-11-10 | Cvi Investments, Inc. | 9.9% |
| Schedule 13G/A, 2025-11-07 | Mitchell P. Kopin | 7% |
| Schedule 13G/A, 2025-11-06 | Orca Capital Ag | 9.8% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-21 | R. Todd Plott | appointed | 2026-07-20 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-12 | $1.42M | $25.93M |
| Form D, 2025-08-04 | $232K | $5.08M |
| Form D, 2025-01-28 | $153K | $3.66M |
| Form D, 2025-01-28 | $266K | $6.38M |
| Form D, 2025-01-28 | $208K | $5M |
| Form D, 2025-01-07 | $30K | $480K |
| Form D, 2025-01-03 | $55K | $1.31M |
| Form D, 2024-07-24 | $136K | $6.36M |
Latest IPO step: Phio Pharmaceuticals Corp. filed to go public (S-1, 2025-01-21).
IPO filings: S-1, 2025-01-21, S-1, 2024-07-26; ticker PHIO on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/phio-pharmaceuticalsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-02-17 · Form D, 2025-11-12 · Form 8-K, 2026-07-21 · S-1, 2025-01-21
Who owns Phio Pharmaceuticals Corp.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/phio-pharmaceuticals